Importantly, TGM2 also supports the trans-differentiation of glioma stem cells by triggering degradation of CEBP Homologous Protein (CHOP/GADD153), leading to a reciprocal increase in CEBPβ levels67. This evidence concerns the gene DDIT3 and central nervous system cancer.